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Introduction. 
Elevated titers of natural antibodies have been 
demonstrated in the sera of patients following trarts-
plantation.1- 6 These humoral responses were thought 
to be associated with rejection .1 - 10 This concept was 
challenged by investigators whose studies associated 
these responses with infection or with injection of 
heterologous serum .11 - 15 Nevertheless, the possible 
prognostic significance of these relatively simple tests 
has continued to evoke interest. 
This study was undertaken to compare the hu-
moral responses in three different groups of patients 
with organ transplants in order to evaluate the in-
fluence of duration of the homograft and the atten-
dant immunosuppression . 
Materials and Methods. 
Patient Selection. 
Fifty-eight patients who had received homo-
grafts were selected for study. The patients were di-
vided into three groups: Group 1, 20 patients tested 
prior to transpla ntation and in the immediate post-
transplant period with a mean duration of follow-up 
of 3.3 months; Group 2, 19 patients tested approxi-
mately five to seven years following transplantation 
with a mean follow-up duration of 82.2 months; and 
Group 3, 19 patients tested approximately ten years 
following transplantation with a mea n follow-up du-
ration of 118.1 months . 
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Tests for Anti-Rat Erythrocyte Antibodies ( Het-
erophil Antibodies). 
Rat erythrocytes were washed three times in sa-
line and reconstituted to a 2% suspension . The test 
sera were tested at a 1: 20 dilution and in serial two-
fold dilution for antibody titer. The tubes were al-
lowed to stand at room temperature for 30 mintues, 
spun for 1 minute at 77 g, and .read with the naked 
eye. 
Tes ls for Rheumatoid Factor ( A nti-Fc IgG anti-
g/obulins ). 
The sensitized human cell test (SHC) was used. 
A selected DCe/ DCe test cell was sensitized with 
Ripley serum (high 0 titered antiDC) diluted 1: 10. The 
Rh-positive cells were sensitized for 60 minutes at 37 
C and then washed three times in saline. Test sera 
were titrated in saline in 0.1 ml volumes. Titers of 
I : 20 or above were considered positive. 
Tests for Chymotrypsin Agglutinators ( Anti-Fab 
IgG Antig/obulins) Hydrolysis of IgG globulins. 
The IgG globulins of anti-Rh serum (Ripley) 
were isolated by (N H4)2S04 precipitation followed by 
chromatography on diethylaminoethyl (DEAE)-cel-
lulose as previously described.16 Methods of hydro-
lysis of the IgG globulins with chymotrypsin have 
been reported. 17 
Sensitizations. One milliliter (containing 5 mg of 
digested globulin) was added to 0.1 ml of human 0, 
DCe/ DCe washed packed cells and sensitized at 37 C 
for one hour. The sensitized cells were washed three 
times with saline and reconstituted to a 2% suspen-
sion. The cells were tested with goat anti-Fe and anti-
Fab (Hyland Laboratories, Los Angeles, California) 
antisera. 
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Methods of testing. Tests for serum agglutinators 
were performed in tubes by adding 0 . 1 ml aliquots of 
the sensitized cells to an equal volume of undiluted 
and serial twofold dilutions of sera to be tested. The 
mixture was allowed to stand at room temperature 
for ten minutes, and then spun for one minute at 77 g 
and read with the naked eye. 
Erythrocyte Sedimentation Rate ( ESR). 
The Westergren method was used to document 
the ESR . The fall of the erythrocytes in millimeters in 
one hour was noted . The normal sedimentation rate 
with this method is O to 15 mm for men with an 
average of 4 mm, and Oto 20 mm for women with an 
average of 5 mm. 
Nitroblue-Tetrazolium Test ( NBT) . 
The NBT test was performed according to the 
modified method of Dorwick'8 on venous blood col-
lected in 4.5 ml vacutainers containing 3.8% sodium 
citrate. The NBT test was performed as soon as pos-
sible after the blood was drawn in order to eliminate 
morphological changes caused by prolonged ex-
posure to the anticoagulant. 
A standard so lution of 0.4% N BT was prepared 
in a 10 ml stoppered volumetric flask by dissolving 20 
mg of nitroblue tetrazolium (Grade Ill reagent, 
N6876, Sigma Chemical Co., St. Louis, Missouri) in 
5 ml of sterile 0.85% isotonic saline. To dissolve the 
NBT, the stoppered flask was swirled under hot, run-
ning tap water until the solution beca me clear. This 
solution was then filtered and transferred to a brown 
bottle and stored at 4°C. The solution was stable for 
72 hours . 
Citrated blood, 0.2 ml, was placed in a test tube 
and 0.1 ml of 0.4% NBT was added. The tube was 
mixed by gently shaking, capped and incubated in a 
water bath at 37 C for 30 minutes . The tube was 
removed from the water bath, and one drop of the 
blood-NBT test mixture was added to two pre-
cleaned, labeled glass slides. Special care was taken to 
avoid damage to the white blood cells . The slides 
were air-dried and stained with Wright's stain. The 
stained slides were examined microscopically using 
an oil immersion lens and 100 neutrophils were 
counted. Neutrophils were classified as "NBT-posi-
tive" if they contained any visible formazan deposits . 
Cells that were disrupted or clumped together were 
not counted . The percent of N BT-positive neutro-
phils was reported as 0% to 15% normal and 16% to 
I 00% normal. 
Serum Electrophoresis. 
Serum electrophoresis was performed on cellu-
lose acetate strips, using the Microzone cell, Model 
R-101 (Beckman Instruments , Inc., Fullerton , Cali-
fornia). 
Results. 
Figure I shows the humoral responses of the 20 
patients in Group I during the first five to six months 
following transplantation. The anti-Fab antiglobu-
lins are design ated by dark circles. These antibodies 
are usually produced as lgG globulins. Only 7 of the 
20 patients showed titers at any time in excess of the 
pretranspla nt values. Titers below I: 20 are shown as 
lines without a dot dipping below the I: 20 titer level. 
Fluctuations in titer are common. 
The a nti-rat erythrocyte a ntibodies are desig-
nated by open circles. These antibodies are almost 
always produced as lgM globulins. Fifty percent (10 
out of 20) of the patients showed titers in the post-
transplant period higher than the pretransplant titer. 
Once again, fluctuations in titer are common. There 
I 640 
"° 160 -eo 
40 
20 
Fig I-Titers of anti-rat erythrocyte antibodies and chymotrypsin 
agg lutin ators in 20 patients in the immediate post-transplant pe-
riod. Open circle: anti-rat erythrocyte: Dark circle: chymotrypsin 
agglu tin ato rs. 
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is a tendency for both antibodies to return toward 
pretransplant levels 9 to 12 months after trans-
plantation. 
Although 4 of these 20 patients gave positive 
tests for rheumatoid factors, on ly 3 (patients 2, 7 and 
13) showed titers in excess of the pretransplant val-
ues. Titers were not constant, as is observed in 
chronic rheumatoid arthritis, but fluctuated, cresting 
and then falling, like the other antibodies. The rheu-
matoid factors were invariably made as IgM globu-
lins. 
Modestly elevated titers of anti-sheep eryth-
rocyte antibodies ( I : 80) were found in only 2 (pa-
tients 3 and 11) of the 20 patients. 
The blood groups of the 58 patients did not 
significantly influence the serological responses of the 
antibodies tested . 
Figure 2 shows the titers of the anti-rat eryth-
rocyte antibodies (lgM globulins) and the anti-Fab 
antiglobulins (IgG globulins) in the three groups of 
patients in order of increasing duration of the homo-
graft and attendant immunosuppression. The titers of 
the antibodies in Group I were read at three months 
post-transplant. The titers of Groups 2 and 3 were 
performed when they appeared for post-transplant 
check-up. It is apparent from Figure 2 that the num-
ber of patients with significant titers of antibodies 
decreases with duration of the homograft. 
Three of the 38 long-term homograft recipients 
(five to ten years) had positive tests for rheumatoid 
factors. Neither the presence nor the titers of the 
rheumatoid factors were related to the duration of 
the graft. One patient who had shown high titers of 
rheumatoid factors in the past lost this activity 11 
years post-transplant. This patient has developed re-
ticulum cell sarcoma. 
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Fig 2-lnfluence of duration .of homograft and attendant immuno-
suppression on humoral antibodies in 58 patients. Triangle: mean 
3.3 months: Dark square: mean 82.2 months; Open square: 118.1 
months. 
Relationship of level of gamma globulin to the 
production of humoral antibody. 
Electrophoretic patterns of tlie serum proteins 
were performed on the three groups of patients. The 
patients were divided into two groups, those with 
gamma globulins below 12% and those with gamma 
globulins above 12% (Table I) . In Group I, 5 out of 
the 6 patients with gamma globulin levels below 12% 
made anti-Fab IgG antibodies as did 9 out of the 14 
with gamma globulin levels above 12%. Thus, 70% of 
Group I made these antibodies. However, in Group 
2, only 2 out of 11 made these antibodies when the 
level of gamma globulin was below 12%, while 3 out 
of 8 made them when the level of gamma globulin 
was above 12%. In the whole group, 26% made these 
antibodies. In Group 3, none of the 6 patients with 
gamma globulin levels below 12% made these IgG 
antibodies, while 5 of the 13 with gamma globulin 
levels above 12% did so. 
A similar pattern is seen for the IgM anti-rat 
erythrocyte antibodies. There appears to be no effect 
of low levels of gamma globulin in the immediate 
post-transplant group (Group I), but in the long-
term patients, the influence of low levels of gamma 
globulin on both the lgG and lgM antibodies is de-
monstrable. 
Table 2 shows the relationship between the se-
rum creatinine levels and the failure to show humoral 
responses in 37 of the long-term transplant recipients . 
Among the 12 patients with elevated levels of creati-
nine, the incidence of both IgG and lgM antibodies is 
decreased. This decrease in antibody production was 
TABLE I 
a) Relationship of level of gamma globulins to 
/gG antibody production as chymotrypsin agglutinator 
Group 1 * 
Group 2** 
Group 3*** 
< 12% 
5/ 6 
2/ 11 
0/ 6 
> 12% 
9/ 14 
3/ 8 
5/ 13 
Total 
14/ 20(70%) 
5/ 19 (26% ) 
5/ 19 (26% ) 
b) Relationship of level of gamma globulins to 
lg M antibody production as anti-rat antibody 
Group 1 * 
Group 2** 
Group 3*** 
< 12% 
6/ 6 
2/ 11 
1/ 6 
* Mean 3.3 months 
•• Mean 82.2 months 
*** Mean 118.1 months 
> 12% 
10/ 14 
3/ 8 
6/ 13 
Total 
16/ 20 (80% ) 
5/ 19 (26%) 
7/ 19 (37%) 
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TABLE 2 
Thirty-seven patients with long-term homografts showing a relationship between the serum creatinine level and failure to show humoral responses 
Creatinine levels: 3.1 and above 
0/ 3 
2.6-3.0 
0/ 1 
IgM Antibody Responses 
(anti-rat erythrocyte antibody) 
2.1-2.5 1.5-2.0 
1/ 6 
0.9-1.4 
11 / 25 0/ 2 
Creatinine levels: 3.1 and above 
0/ 3 
2.7-3.0 
0/ 1 
IgG Antibody Responses 
(chymotrypsin agglutinators) 
2.1-2.5 1.5-2.0 
0/ 6 
0.9-1.4 
I 0/ 25 
not related to a significantly higher dose of mainte-
nance immunosuppression . 
Since infection plays a prominent role in patients 
maintained for long periods on immunosuppressive 
agents, the erythrocyte sedimentation rate and the 
NBT test were performed on 37 of the 38 patients in 
Group 2 and 3. The erythrocyte sedimentation test 
was abnormal in 24 of the 37 patients (65%). The 
numerous factors affecting this test, such as anemia 
and dysglobulinemia, lessen the value of this test for 
evaluation of patients with positive tests. The NBT 
test was only positive in 3 of the 37 long-term pa-
tients. Careful review of the discharge summaries 
corresponding to the period at which the test was 
done failed to reveal a reason for these abnormal 
tests. In a further effort to evaluate the significance of 
these positive tests, C3 and C4 levels were determined 
on these patients' sera along with 12 other patients 
who did not show positive NBT tests. The levels of 
C3 and C4 were not significantly altered in the pa-
tients with positive NBT tests. 
Discussion. 
These studies document humoral antibody activ-
ity in the immediate post-transplant period. Rises in 
titer of both IgG antibodies (anti-Fab lgG antiglobu-
lins) and lgM antibodies (anti-rat erythrocyte anti-
bodies) are demonstrable. The antibody rises are usu-
ally inverse to each other, implying that different 
antigens elicit these responses. The antigens on the 
rat erythrocyte are also found on dog and rabbit 
erythrocytes, and related antigens are present on hu-
man B erythrocytes. Thus, the antibodies are termed 
heterophils . McDonald and co-workers19 recently 
studied these antibodies and related the absence of 
the "rat" antigen (HT-A) in the recipients to in-
creased rejection of kidneys from donors with the 
antigen . Their studies have clinical importance and 
help to define complex tissue antigens which will 
receive more attention in the future. 
Rises in titer of the anti-Fab lgG antiglobulins 
0/ 2 
could not be closely associated with rejection. These 
antiglobulins are associated with severe suppurative 
infection in a hospitalized population. 16 In post-
transplant patients, there is a tendency for these an-
tiglobulins to rise when the titers of the anti-rat eryth-
rocyte antibodies are falling, 14 which suggests that 
these are auxiliary immune responses or responses to 
antibody-antigen complexes. 
The dramatic serological responses in the imme-
diate post-transplant period are not repeated in sub-
sequent years. This is probably due to immunosup-
pressivt: therapy. However, we observed no inhibition 
of polymorphonuclear phagocytosis nor depression 
of C3 or C4 levels . On the other hand, laboratory 
tests for infection (sedimentation rate, NBT test) may 
react nonspecifically, making the diagnosis of occult 
infection difficult. 
As all those interested in transplantation know, 
the greatest drawback in currently available methods 
of immunosuppression is their nonspecificity. This 
fact has stimulated interest in immunological en-
hancement of the kidney graft. Evidence exists that 
kidney grafts in rats can survive by virtue of enhance-
ment.20-25 One approach in humans entailed the pro-
duction of immune sera to leukocyte antigens, fol-
lowed by the hydrolysis of the antibody to remove the 
complement-fixing Fe fragment. The resulting Fab 
fragments were injected into the recipient to bind to 
the antigenic sites on the graft. 26 As discussed pre-
viously, the serum agglutinators are antiglobulins 
which have specificity for Fab fragments following 
hydrolysis. These antiglobulins are naturally occur-
ring lgG globulins commonly found in low titer. 
However, the serum agglutinators (named homoreac-
tant in rabbits) are not apparently stimulated by the 
injection of Fab fragments, 27 but once stimulated, 
their ability to reconstitute the biological potential of 
the Fab fragment has been established. 28 Therefore, it 
would be essential to test the recipient for these anti-
globulins prior to the injection of the Fab fragments . 
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In any case, the role of the anti-Fab antiglobulins 
must be considered when Fab fragments are used to 
achieve blocking of the antigenic sites of a homo-
graft. 
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